Table 1.
Immunoglobulin and Other Immunoreceptor Folds
Protein/complex |
Domain/region |
Folda |
PDBb |
References |
---|---|---|---|---|
Immunoglobulins | ||||
Antibodies |
1igt |
Harris et al. (1997) |
||
Variable region |
V‐ type |
|||
Constant region |
C1‐type |
|||
Major histocompatibility complexes | ||||
MHC class I |
2clr |
|||
Heavy chain α1+α2 domain |
MHC |
|||
Heavy chain α3 domain |
C1‐type |
|||
β2‐microglobulin |
C1‐type |
|||
MHC class II |
1aqd |
Brown et al. (1993) |
||
Heavy chain α1+β1 domain |
MHC |
|||
α chain, C‐terminal domain |
C1‐type |
|||
β chain, C‐terminal domain |
C1‐type |
|||
Cell surface immunoglobulin‐like receptors | ||||
T‐cell receptor, αβ type |
1ao7 |
Garboczi et al. (1996) |
||
Vα, Vβ domains |
V‐type |
|||
Cβ domain |
C1‐type |
|||
CD8, T‐cell coreceptor |
V‐type |
1cd8 |
Leahy et al. (1992a) |
|
Neonatal Fcγ receptor |
1fru |
Burmeister et al. (1994) |
||
Heavy chain α3 domain |
C1‐type |
|||
β chain |
C1‐type |
|||
Growth hormone receptor |
||||
Domains 1 and 2 |
C2(Fn) |
3hhr |
de Vos et al. (1992) |
|
EPO receptor |
C2(Fn) |
1ern |
Livnah et al. (1999) |
|
Prolactin receptor |
||||
Domains 1 and 2 |
C2(Fn) |
1bp3 |
Somers et al. (1994) |
|
IFN‐γ receptor |
C2(Fn) |
1fg9 |
Walter et al. (1995) |
|
FGFR2 |
I‐C2 |
1e0o |
Pellegrini et al. (2000) |
|
GCSFR |
C2(Fn) |
1cd9 |
Aritomi et al. (1999) |
|
IL‐10R |
C2(Fn) |
1j7v |
Josephson et al. (2001) |
|
IL‐4R |
C2(Fn) |
1iar |
Hage et al. (1999) |
|
Gp130 receptor |
C2(Fn) |
1i1r |
Chow et al. (2001) |
|
CD4, T‐cell surface glycoprotein |
3cd4 |
Ryu et al. (1990) Wang et al. (1990) |
||
Domains 1 and 3 |
V‐typec |
|||
Domains 2 and 4 |
C2‐like |
|||
Fcγ receptor, type III |
C2‐like |
1fnl |
Zhang et al. (2000) |
|
Fcγ receptor, types IIA and IIB |
C2‐like |
1fcg |
Maxwell et al. (1999) |
|
Fcɛ receptor, type I |
C2‐like |
1f2q |
Garman et al. (1998) |
|
Coagulation factor | ||||
Tissue factor |
Ectodomain |
C2(Fn) |
2hft |
Muller et al. (1996) |
Cell matrix and adhesion proteins | ||||
Fibronectin |
Type III domain |
C2(Fn) |
1fna |
Main et al. (1992) |
Tenascin, repeats |
C2(Fn) |
1ten |
Leahy et al. (1992b) |
|
CD2 |
1hnf |
Jones et al. (1992) |
||
Adhesion domain |
V‐type |
|||
C‐terminal domain |
C2 like |
|||
VCAM‐1 |
1vca |
Jones et al. (1995) |
||
Domain 1 |
I‐type |
|||
Domain 2 |
C2 like |
|||
Cadherind |
C1 type |
1nci |
Shapiro et al. (1995) |
|
Muscle proteins | ||||
Telokin |
I‐type |
1tlk |
Holden et al. (1992) |
|
Titin |
I‐type |
1tnm |
Pfuhl and Pastore (1995) |
|
Transcription factors e | ||||
NF‐κB, p50 subunit |
1nfk |
|||
First Rel homology domainf |
E‐type |
1svc |
Muller et al. (1995) |
|
Second Rel homology domain |
E‐type |
|||
Enzymes with immunoglobulin‐like domains | ||||
Chaperone protein, papD |
3dpa |
Holmgren and Branden (1989) |
||
Domain 1g |
C2 |
|||
Domain 2h |
C2 |
|||
Oxidoreductase | ||||
Cu, Zn superoxide dismutasei |
C2 |
2sod |
Richardson et al. (1976) |
|
Galactose oxidase |
C domain |
E‐type |
1gof |
Ito et al. (1991) |
Transferase | ||||
Cyclodextrin glycosyltransferase |
E‐type |
1cdg |
Lawson et al. (1994) |
|
Lyase | ||||
Chitinase A |
N‐terminal domain |
E‐type |
1ctn |
Perrakis et al. (1994) |
C‐type lectin‐like receptors | ||||
Mannose binding protein (MBP) |
CTLR |
1msb |
Weis et al. (1991) |
|
CD94 |
CTLR |
1b6e |
Boyington et al. (1999) |
|
Ly48A |
CTLR |
1qo3 |
Tormo et al. (1999) |
|
NKG2D |
CTLR |
1hq8 |
Wolan et al. (2001) |
|
DC‐SIGN |
CTLR |
1k9j |
Feinberg et al. (2001) |
|
Immunoreceptor‐ligand complexes | ||||
A6 TCR/HLA‐A2(Tax) |
TCR‐MHC |
1ao7 |
Garboczi et al. (1996) |
|
2C TCR/H‐2Kb(dEV8) |
TCR‐MHC |
2ckb |
Garcia et al. (1998) |
|
CD8/HLA‐A2 |
CD8/MHC‐I |
1akj |
Gao et al. (1997) |
|
CD4/I‐A(k) |
CD4/MHC‐II |
1jl4 |
Wang et al. (2001) |
|
B7‐1/CTLA‐4 |
B7/CTLA‐4 |
1i84 |
Stamper et al. (2001) |
|
KIR2DL2/HLA‐Cw3 |
KIR/HLA |
1efx |
Boyington et al. (2000) |
|
KIR2DL1/HLA‐Cw4 |
KIR/HLA |
1im9 |
Fan et al. (2001) |
|
NKG2D/MICA |
NKG2D/ligand |
1hyr |
Li et al. (2001) |
|
NKG2D/ULBP3 |
NKG2D/ligand |
1kcg |
Radaev et al. (2001b) |
|
NKG2D/Rae‐1b |
NKG2D/ligand |
1jsk |
Li et al. (2002b) |
|
FcɛRI/Fc |
FcR/Fc |
1f6a |
Garman et al. (2000) |
|
FcγRIII/Fc |
FcR/Fc |
1iis, 1iix, 1e4k |
||
MHC‐like molecules | ||||
HLA‐A2 |
MHC |
2clr |
Bjorkman et al. (1987) |
|
HLA‐Aw6B |
MHC |
1hsb |
Garrett et al. (1989) |
|
HLA‐B27 |
MHC |
1hsa |
Madden et al. (1992) |
|
H‐2Kb |
MHC |
1vac |
||
HLA‐DR1 |
MHC |
1aqd |
||
Neonatal Fc receptor |
MHC |
1fru |
Burmeister et al. (1994) |
|
HLA‐DM |
MHC |
1k8i |
Fremont et al. (1998) |
|
HLA‐E |
MHC |
1mhe |
O'Callaghan et al. (1998) |
|
CD1 |
MHC |
1cd1 |
Zeng et al. (1997) |
|
Zinc α‐2‐glycoprotein (Zag) |
MHC |
1zag |
Sanchez et al. (1999) |
|
MIC‐A |
MHC |
1b3j |
Li et al. (1999) |
|
T22 |
MHC |
1c16 |
Wingren et al. (2000) |
See Proteins Involved in the Function of Immune Systems for explanations of folds.
Strand A pairs with strand G only.
Strand A pairs with strand G instead of B.
See also Table 6.
Insertion strands between strands C and C′, and E and F.
Strand A pairs with both B and G.
One additional strand at C terminus.
One additional strand at N terminus.
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.